Clinical Trials

Papers
(The H4-Index of Clinical Trials is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)91
The Bayesian Time Machine: Accounting for temporal drift in multi-arm platform trials30
Intra-cluster correlations from the CLustered OUtcome Dataset bank to inform the design of longitudinal cluster trials25
COVID-19 vaccine trials: The use of active controls and non-inferiority studies23
Online monitoring of patient self-reported adverse events in early phase clinical trials: Views from patients, clinicians, and trial staff21
Meta-analysis of rare adverse events in randomized clinical trials: Bayesian and frequentist methods19
Characteristics of available studies and dissemination of research using major clinical data sharing platforms19
Strategies for research participant engagement: A synthetic review and conceptual framework18
Now is the time to fix the clinical research workforce crisis18
Design and implementation of an international, multi-arm, multi-stage platform master protocol for trials of novel SARS-CoV-2 antiviral agents: Therapeutics for Inpatients with COVID-19 (TICO/ACTIV-3)17
Blinding, sham, and treatment effects in randomized controlled trials for back pain in 2000–2019: A review and meta-analytic approach17
Now is the time to fix the evidence generation system16
An ethics framework for consolidating and prioritizing COVID-19 clinical trials15
When is it impractical to ask informed consent? A systematic review15
Clinical trials site recruitment optimisation: Guidance from Clinical Trials: Impact and Quality14
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–201814
Phase I trial compensation: How much do healthy volunteers actually earn from clinical trial enrollment?14
The U.S. Food and Drug Administration’s Complex Innovative Trial Design Pilot Meeting Program: Progress to date14
Clarifying selection bias in cluster randomized trials14
0.077388048171997